吉林省奇健生物技术

Jilin Qijian Biotechnology is a biopharmaceutical company based in Changchun, China, specializing in the research, development, and large-scale manufacturing of human vaccines. The company's primary commercial product is a freeze-dried human rabies vaccine produced using Vero cell technology and advanced bioreactor systems. Operating from a modern GMP-certified facility, Jilin Qijian utilizes microcarrier culture processes to ensure high-capacity and high-quality production of biological products. The company focuses on addressing critical public health needs in the prevention of infectious diseases within the Chinese domestic market. It is recognized as a high-tech enterprise in Jilin Province and continues to invest in technological innovation for vaccine production.